Drug Discovery Technologies Market, By Drug Type (Biologics, Small molecule drugs, Cell & gene therapies, Vaccines, and Protein & peptide drugs), By Technology, By Application, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV5515
|
Published Date
July 2026
|
Pages
444
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Drug Discovery Technologies Market size was valued at USD 43,506.1 Million in 2025, expanding to a CAGR of 11.3% from 2026 to 2033.
Drug discovery technologies refer to a range of scientific methods, computational tools, and advanced research platforms used to identify, design, and develop new therapeutic drugs. These technologies play a crucial role in the early stages of the drug development process by enabling researchers to identify disease-related biological targets, screen large compound libraries, and optimize promising drug candidates for further evaluation and clinical testing. They also support key activities such as understanding disease pathways, predicting drug–target interactions, and assessing compound safety and efficacy.
From a global healthcare and regulatory perspective, government-backed research institutions and funding bodies—such as the U.S. National Institutes of Health (NIH), the European Medicines Agency (EMA), and national science and health ministries across multiple countries—are actively supporting advancements in drug discovery innovation. Increasing public investment in biomedical research and precision medicine initiatives worldwide is accelerating the adoption of AI-driven and high-throughput drug discovery platforms, further improving the speed and efficiency of new drug development processes.
Drug Discovery Technologies Market- Market Dynamics
Rising Incidence of Cancer and Neurological Disorders, Combined with Rapid Advances in Genomics, Driving Market Growth
The drug discovery technologies market is experiencing robust growth as pharmaceutical and biotechnology companies seek to accelerate the development of safe, effective, and innovative therapies. The rising prevalence of chronic and complex diseases—including cancer, neurological disorders, autoimmune diseases, and rare genetic conditions—is significantly increasing the demand for advanced drug discovery solutions. Conventional drug discovery approaches are often time-consuming, costly, and associated with high failure rates, prompting organizations to adopt more efficient, technology-driven research platforms. Modern drug discovery technologies enable researchers to identify biological targets, screen large compound libraries, and optimize drug candidates with greater speed, precision, and predictive accuracy. Furthermore, the growing emphasis on precision medicine and personalized healthcare is driving the adoption of sophisticated discovery platforms capable of supporting targeted therapeutic development.
From a global perspective, government agencies and public health organizations are substantially increasing investments in biomedical research to address the growing burden of chronic diseases. Institutions such as the U.S. National Institutes of Health (NIH), the European Union through Horizon Europe, and national health research agencies across Asia-Pacific are funding large-scale drug discovery, genomics, and translational medicine programs. These initiatives are accelerating scientific innovation and strengthening the adoption of advanced drug discovery technologies worldwide.
Rapid advancements in genomics are further transforming the drug discovery landscape by providing deeper insights into the genetic factors that influence disease progression and patient response to therapy. Genomic technologies are playing a central role in the evolution of precision medicine by enabling the development of highly targeted and personalized treatment strategies. As healthcare providers and pharmaceutical companies increasingly focus on individualized therapies, demand for advanced platforms capable of analyzing complex genomic datasets continues to grow. In addition, expanding genomic databases, next-generation sequencing technologies, and advanced bioinformatics tools are creating new opportunities for data-driven drug discovery. These technologies are particularly valuable in oncology, rare diseases, inherited disorders, and other genetically driven conditions where understanding molecular mechanisms is essential for identifying novel therapeutic targets. Continuous investment in genomics research, supported by government-funded precision medicine initiatives and collaborative research programs, is expected to further accelerate innovation and drive long-term growth in the global drug discovery technologies market.
Drug Discovery Technologies Market- Segmentation Analysis:
The Global Drug Discovery Technologies Market is segmented on the basis of Drug Type, Technology, Application, End-Use, and Region.
The drug discovery technologies market is segmented by drug type into biologics, small molecule drugs, cell and gene therapies, vaccines, protein and peptide drugs, and others. Among these, the small molecule drugs segment accounts for a substantial share of the market owing to its extensive use in the treatment of a wide range of diseases, including cancer, cardiovascular disorders, infectious diseases, metabolic disorders, and neurological conditions. Small molecule therapeutics continue to represent a significant portion of approved pharmaceuticals due to their well-established development pathways, oral bioavailability, cost-effective manufacturing, and proven clinical efficacy. According to global health agencies such as the World Health Organization (WHO), the growing burden of non-communicable diseases worldwide is increasing the need for effective therapeutic agents, thereby supporting continued investment in small molecule drug discovery.
Drug discovery technologies play a pivotal role in the development of small molecule drugs by enabling target identification and validation, high-throughput compound screening, molecular modeling, structure-based drug design, lead optimization, and preclinical candidate selection. The integration of artificial intelligence (AI), machine learning, computational chemistry, and high-content screening platforms is significantly improving the efficiency and success rates of small molecule discovery programs. These advanced technologies allow pharmaceutical companies to reduce development timelines, improve candidate selection, and optimize research productivity.
In addition, pharmaceutical and biotechnology companies continue to allocate substantial research and development investments toward small molecule drug programs because of their broad therapeutic applicability, established regulatory pathways, and relatively lower manufacturing complexity compared with many advanced biologic therapies. Government-supported biomedical research initiatives, including those funded by organizations such as the U.S. National Institutes of Health (NIH), the European Union\'s Horizon Europe programme, and national life science research agencies across Asia-Pacific, are further accelerating innovation in small molecule drug discovery. Collectively, these factors are expected to sustain the segment\'s leading position in the global drug discovery technologies market over the forecast period.
Drug Discovery Technologies Market- Geographical Insights
The Asia-Pacific region is emerging as a major growth hub for the drug discovery technologies market, driven by substantial investments in pharmaceutical research, biotechnology, and life sciences. Countries such as China, India, Japan, and South Korea are strengthening their research capabilities through the expansion of advanced laboratory infrastructure, increasing healthcare expenditure, and a growing number of clinical and translational research programs. The region also benefits from a large patient population, a skilled scientific workforce, and supportive government initiatives aimed at promoting biotechnology innovation and domestic drug development. These factors are encouraging both local and multinational pharmaceutical companies to expand their research and development activities across the region. From a global policy perspective, governments across Asia-Pacific are implementing strategic programs to strengthen their biopharmaceutical sectors through research funding, innovation incentives, and public-private collaborations. These initiatives are accelerating the adoption of advanced drug discovery technologies, including artificial intelligence, high-throughput screening, genomics, and computational biology, to improve the efficiency of new drug development.
Meanwhile, the drug discovery technologies market in Latin America and the Middle East & Africa is witnessing steady growth as healthcare infrastructure and scientific research capabilities continue to advance. Governments and research institutions in these regions are increasing investments in biomedical research, expanding healthcare innovation programs, and strengthening partnerships with international pharmaceutical companies and academic organizations. Growing participation in global clinical research, coupled with rising funding for life sciences and biotechnology, is creating favorable conditions for the wider adoption of modern drug discovery technologies across these emerging markets.
Mexico Drug Discovery Technologies Market- Key Insights
Mexico is emerging as an important market for drug discovery technologies, supported by the continued expansion of its pharmaceutical industry and increasing investments in biomedical research. Stronger collaboration between domestic research institutions, academic organizations, and global life sciences companies is enhancing the country\'s research capabilities and fostering the development of innovative therapeutic solutions. Government initiatives to strengthen the healthcare and biotechnology sectors are also contributing to the growth of pharmaceutical research and development activities.
In addition, a growing number of biotechnology startups are accelerating innovation by adopting advanced drug discovery technologies such as computational biology, molecular modeling, artificial intelligence, and data-driven research platforms. These technologies enable researchers to identify promising drug candidates more efficiently, improve target validation, and shorten early-stage drug development timelines. As research productivity continues to improve and investments in pharmaceutical innovation increase, the adoption of advanced drug discovery technologies is expected to grow steadily across Mexico in the coming years.
Drug Discovery Technologies Market- Competitive Landscape:
The drug discovery technologies market is highly competitive, with technology providers, pharmaceutical companies, biotechnology firms, and artificial intelligence (AI) developers continuously investing in innovative research platforms to accelerate drug development. Competition is primarily centered on improving the speed, accuracy, and efficiency of early-stage drug discovery through advanced technologies such as AI, machine learning, high-throughput screening, computational chemistry, and predictive analytics. Companies are increasingly developing integrated platforms capable of analyzing complex biological and chemical datasets to support faster target identification, lead optimization, and data-driven decision-making.
The competitive landscape is also being shaped by rapid advancements in genomics, proteomics, multi-omics, and bioinformatics, which are enabling more comprehensive analysis of disease mechanisms and therapeutic targets. To strengthen their market position, leading companies are enhancing their discovery platforms with sophisticated analytical capabilities, cloud-based research tools, and AI-powered predictive models. In addition, strategic collaborations between pharmaceutical companies, biotechnology firms, academic institutions, and technology providers are accelerating innovation and facilitating the development of next-generation drug discovery solutions.
Recent Developments:
- January 2025: Owkin introduced Owkin K1.0 Turbigo, an AI-powered platform designed to accelerate drug discovery, therapeutic development, and diagnostic research. The platform combines advanced artificial intelligence models with intelligent digital agents to generate biological insights, streamline research workflows, and improve decision-making throughout the drug discovery process.
- January 2025: Absci and Owkin announced a strategic collaboration to strengthen AI-driven drug discovery capabilities. The partnership integrates Owkin\'s expertise in AI-based target identification with Absci\'s generative AI platform for biologics design, with the objective of accelerating the discovery and development of novel therapeutic candidates.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET KEY PLAYERS
- Thermo Fisher Scientific
- Danaher Corporation
- Agilent Technologies
- PerkinElmer
- Bio-Rad Laboratories
- Illumina
- Waters Corporation
- Bruker Corporation
- Charles River Laboratories
- Evotec SE
- Schrödinger
- Certara
- IQVIA
- Benchling
- Recursion Pharmaceuticals
- Owkin
- Others
GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET, BY DRUG TYPE- MARKET ANALYSIS, 2020-2033
- Biologics
- Small molecule drugs
- Cell & gene therapies
- Vaccines
- Protein & peptide drugs
- Others
GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020-2033
- High-Throughput Screening (HTS)
- Genomics and Proteomics Technologies
- Combinatorial Chemistry
- Computational Drug Discovery
- Pharmacogenomics
- Others
GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET, BY APPLICATION- MARKET ANALYSIS, 2020-2033
- Neurology
- Cardiovascular Diseases
- Infectious Diseases
- Immunology and Autoimmune Disorders
- Oncology
- Others
GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET, BY END-USE- MARKET ANALYSIS, 2020-2033
- Pharmaceutical & Biotech Companies
- Contract Research Organizations (CROs)
- Academic Research
- Others
GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET, BY REGION- MARKET ANALYSIS, 2020-2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Drug Discovery Technologies Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Drug Discovery Technologies Market Snippet by Drug Type
2.1.2. Drug Discovery Technologies Market Snippet by Technology
2.1.3. Drug Discovery Technologies Market Snippet by Application
2.1.4. Drug Discovery Technologies Market Snippet by End-Use
2.1.5. Drug Discovery Technologies Market Snippet by Country
2.1.6. Drug Discovery Technologies Market Snippet by Region
2.2. Competitive Insights
3. Drug Discovery Technologies Key Market Trends
3.1. Drug Discovery Technologies Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Drug Discovery Technologies Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Drug Discovery Technologies Market Opportunities
3.4. Drug Discovery Technologies Market Future Trends
4. Drug Discovery Technologies Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Drug Discovery Technologies Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Drug Discovery Technologies Market Landscape
6.1. Drug Discovery Technologies Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Drug Discovery Technologies Market – By Drug Type
7.1. Overview
7.1.1. Segment Share Analysis, By Drug Type, 2025 & 2033 (%)
7.1.2. Biologics
7.1.3. Small molecule drugs
7.1.4. Cell & gene therapies
7.1.5. Vaccines
7.1.6. Protein & peptide drugs
7.1.7. Others
8. Drug Discovery Technologies Market – By Technology
8.1. Overview
8.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
8.1.2. High-Throughput Screening (HTS)
8.1.3. Genomics and Proteomics Technologies
8.1.4. Combinatorial Chemistry
8.1.5. Computational Drug Discovery
8.1.6. Pharmacogenomics
8.1.7. Others
9. Drug Discovery Technologies Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
9.1.2. Neurology
9.1.3. Cardiovascular Diseases
9.1.4. Infectious Diseases
9.1.5. Immunology and Autoimmune Disorders
9.1.6. Oncology
9.1.7. Others
10. Drug Discovery Technologies Market – By End-Use
10.1. Overview
10.1.1. Segment Share Analysis, By End-Use, 2025 & 2033 (%)
10.1.2. Pharmaceutical & Biotech Companies
10.1.3. Contract Research Organizations (CROs)
10.1.4. Academic Research
10.1.5. Others
11. Drug Discovery Technologies Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
11.2.1. Overview
11.2.2. Drug Discovery Technologies Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.2.4. North America Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.2.5. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.6. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.7. North America Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Drug Discovery Technologies Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Drug Discovery Technologies Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Drug Discovery Technologies Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Drug Discovery Technologies Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- Drug Discovery Technologies Industry
12.1. Competitive Dashboard
12.1.1. Competitive Benchmarking
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Thermo Fisher Scientific
12.2.2. Danaher Corporation
12.2.3. Agilent Technologies
12.2.4. PerkinElmer
12.2.5. Bio-Rad Laboratories
12.2.6. Illumina
12.2.7. Waters Corporation
12.2.8. Bruker Corporation
12.2.9. Charles River Laboratories
12.2.10. Evotec SE
12.2.11. Schrödinger
12.2.12. Certara
12.2.13. IQVIA
12.2.14. Benchling
12.2.15. Recursion Pharmaceuticals
12.2.16. Owkin
12.2.17. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET KEY PLAYERS
- Thermo Fisher Scientific
- Danaher Corporation
- Agilent Technologies
- PerkinElmer
- Bio-Rad Laboratories
- Illumina
- Waters Corporation
- Bruker Corporation
- Charles River Laboratories
- Evotec SE
- Schrödinger
- Certara
- IQVIA
- Benchling
- Recursion Pharmaceuticals
- Owkin
- Others
GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET, BY DRUG TYPE- MARKET ANALYSIS, 2020-2033
- Biologics
- Small molecule drugs
- Cell & gene therapies
- Vaccines
- Protein & peptide drugs
- Others
GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020-2033
- High-Throughput Screening (HTS)
- Genomics and Proteomics Technologies
- Combinatorial Chemistry
- Computational Drug Discovery
- Pharmacogenomics
- Others
GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET, BY APPLICATION- MARKET ANALYSIS, 2020-2033
- Neurology
- Cardiovascular Diseases
- Infectious Diseases
- Immunology and Autoimmune Disorders
- Oncology
- Others
GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET, BY END-USE- MARKET ANALYSIS, 2020-2033
- Pharmaceutical & Biotech Companies
- Contract Research Organizations (CROs)
- Academic Research
- Others
GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET, BY REGION- MARKET ANALYSIS, 2020-2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
